Clinical Trial Update: Advanta VXT and Flixene PMCF Registry

View source ↗

Summary

The trial registry update shows ongoing recruitment for the Advanta VXT device within the Flixene PMCF Registry for Peripheral Arterial Disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Arterial Disease

Drugs mentioned

• Advanta VXT
• Flixene PMCF Registry

Snippet

Sponsor: Atrium Medical Corporation | Conditions: Peripheral Arterial Disease | Status: RECRUITING